GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / Biovis / Stat3 Peptide Inhibitor, Cell_Permeable / Product Detail : 1778-5 Stat3 Peptide Inhibitor, Cell_Permeable
Related keywords:
Sep
29th
#1778-5 Stat3 Peptide Inhibitor, Cell_Permeable
| Price : | 848 | EUR |
| 963 | USD | |
| 658 | GBP | |
| 3563 | Zloty | |
| 113510 | JPY | |
| 6542 | NOK | |
| 7010 | SEK | |
| 959 | CHF |
Product name : Stat3 Peptide Inhibitor, Cell_Permeable
Catalog number : 1778-5
Quantity: 5 mg
Availability: Yes
Supplier name : Biovis
Data sheet: Ask more or other datasheet now !
More Details about
Alternate Name/Synonyms: PY*LKTK-mts (where Y* = phosphotyrosine)
Peptide sequence: H-Pro-Tyr-(PO₃H₂)-Leu-Lys-Thr-Lys-Ala-Ala-Val-Leu-Leu-Pro-Val-Leu-Leu-Ala-Ala-Pro-OH. CF3CO2H
Appearance: White lyophilized solid
Formulation: N/A
CAS Number: N/A
Molecular Formula: C₉₂H₁₅₇N₂₀O₂₄P .C₂HF₃O₂
Molecular Weight: 1958.32 . 114.02
Purity: ≥95% by HPLC
Solubility: H₂O
Storage Temp.: -20°C
Shipping Conditions: gel pack
Description: Cell-permeable. A peptide-based inhibitor, PY*LKTK-mts (mts = membrane translocating sequence) that selectively inhibits constitutive and ligand-induced activation of Stat3 in vivo. Also suppresses transformation by Src oncoprotein that requires constitutive Stat3 activation.
Handling: Protect from air and moisture
USAGE: For Research Use Only! Not For Use in Humans.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Stat3 Peptide Inhibitor, Cell_Permeable
Related products : Stat3 Peptide Inhibitor, Cell_Permeable
other names
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Related products : Stat3 Peptide Inhibitor, Cell_Permeable
Gentaurpub
WP10: IL-9 Signaling Pathway
WP1001: Peptide GPCRs
WP1004: Kit Receptor Signaling Pathway
WP1012: IL-7 Signaling Pathway
WP1025: B Cell Receptor Signaling Pathway
WP1031: IL-3 Signaling Pathway
WP1033: ACE Inhibitor Pathway
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP1048: TGF Beta Signaling Pathway
WP1064: Delta-Notch Signaling Pathway
WP1087: IL-5 Signaling Pathway
WP1091: IL-2 Signaling Pathway
WP1092: IL-9 Signaling Pathway
WP1094: IL-6 Signaling Pathway
WP1096: EGFR1 Signaling Pathway
WP1105: Adipogenesis
WP1112: EPO Receptor Signaling
WP1117: Peptide GPCRs
WP1121: Kit Receptor Signaling Pathway
WP113: TGF Beta Signaling Pathway
WP1131: IL-7 Signaling Pathway
WP1144: B Cell Receptor Signaling Pathway
WP1150: IL-3 Signaling Pathway
WP1151: ACE Inhibitor Pathway
WP1162: Signaling of Hepatocyte Growth Factor Receptor
Related Genes :
[STAT3 APRF] Signal transducer and activator of transcription 3 (Acute-phase response factor)
[Stat3 Aprf] Signal transducer and activator of transcription 3 (Acute-phase response factor)
[stat3.1 stat3] Signal transducer and activator of transcription 3.1 (Protein Stat3) (Xstat3)
[Stat3] Signal transducer and activator of transcription 3
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[stat3] Stat3 protein
[stat3] Transcription factor Stat3 (Fragment)
[STAT3] Signal transducer and activator of transcription 3
[stat3.2 stat3-a] Signal transducer and activator of transcription 3.2 (Protein Stat3-A)
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[KIT SCFR] Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)
[IFNAR2 IFNABR IFNARB] Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
[STAT3] Signal transducer and activator of transcription 3
[ELP2 STATIP1] Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)
[Ooep Oep19 Sddr] Oocyte-expressed protein homolog (Factor located in oocytes permitting embryonic development) (Floped) (Oocyte- and embryo-specific protein 19) (mOEP19) (STAT3 downstream gene and differentiation regulator)
[STAT3 RCJMB04_38l20] Signal transducer and activator of transcription 3
[stat3 Stat3] Signal transducer and activator of transcription
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[Lepr Db Obr] Leptin receptor (LEP-R) (B219) (OB receptor) (OB-R) (CD antigen CD295)
[Fer Fert2] Tyrosine-protein kinase Fer (EC 2.7.10.2) (Proto-oncogene c-Fer) (p94-Fer)
[BIRC5 API4 IAP4] Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin)
[ERBB2 HER2 MLN19 NEU NGL] Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
[Elp2 Statip1] Elongator complex protein 2 (ELP2) (STAT3-interacting protein 1) (StIP1)
[IGF1R] Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain]
[RET CDHF12 CDHR16 PTC RET51] Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[stat3] Signal transducer and activator of transcription
[stat3] Signal transducer and activator of transcription
[stat3] Signal transducer and activator of transcription
[Kit Sl] Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117)
Bibliography :
[27676194] Folic acid supports pluripotency and reprogramming by regulating LIF-STAT3 and MAPK-ERK signaling.
[27676011] Stat3 Activation Mediates Stem Cell, DNA Repair, and Immunosuppressive Properties in Crizotinib-Resistance ELM4-ALK-Rearranged Lung Cancer.
[27673353] Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.
[27672444] NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K-AKT and JAK-STAT3 pathways.
[27672275] Impact of Helicobacter pylori on the healing process of the gastric barrier.
[27671827] Garcinol and Its Role in Chronic Diseases.
[27671820] Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.
[27671679] ZIC5 drives melanoma aggressiveness by PDGFD-mediated activation of FAK and STAT3.
[27671678] Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes.
[27671645] Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.
Share this page:
Enter catalog number :
Favorites Pages:
No Favorits